🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“I hope that other families never have to go through this,” Stephanie Dobson says. “But if they do, that it’s as supported and informed as ours is.” #ColorectalCancerAwarenessMonth #DanaFarber #LynchSyndrome ms.spr.ly/6016ct4Tu

How can the electronic health record (EHR) be leveraged to understand the magnitude of #LynchSyndrome underdiagnosis? Can we use the EHR to identify gaps underlying this problem? Our editorial for JCO Clinical Cancer Informatics: ascopubs.org/doi/full/10.12… Thank you Matt Yurgelun, MD ! CGA-IGC

nature.com/articles/s4159… fantastic innovation for refractory #colorectalcancer ⁦Dana-Farber⁩ ⁦Dana-Farber's Young-Onset Colorectal Cancer Center⁩ ⁦Dana-Farber News⁩ ⁦BIDMC⁩ ⁦Anthony El-Khoueiry⁩ ⁦Dr. Marwan G. Fakih⁩ ⁦Bruno Bockorny MD FACP⁩ ⁦Agenus⁩

The Dana-Farber #LynchSyndrome Center is representing at the annual @FacingOurRisk conference!

Excited & honored to share this story of discovery and prevention in #LynchSyndrome ⁦Gastroenterology⁩ This work is key to why I pursued a career studying & treating Lynch Syndrome and GI cancers Thanks to Dr. Boland for bringing me along for the ride gastrojournal.org/article/S0016-…

On October 6, I’ll be walking to raise money for the Dana-Farber Lynch Syndrome Center 100% of funds raised will support #LynchSyndrome education, research, and patient care Click here to donate ▶️▶️ danafarber.jimmyfund.org/goto/Yurgelun

New ⁦National Comprehensive Cancer Network (NCCN)⁩ guidelines for Breast/Ovarian/Pancreatic Cancer Genetics posted at nccn.org/professionals/… New recommendation that #PancreaticCancer screening be “considered” for all BRCA2 and ATM pathogenic variant carriers by age 50, even without known family history

One week from tomorrow! ⬇️⬇️

Are you at the CGA-IGC Annual Meeting (or wish you were)? Then you will undoubtedly enjoy the FREE Dana-Farber #LynchSyndrome Center’s Scientific Symposium Wed April 16, 2025. Registration is now open, *and* we are calling for abstract submissions this year #CGAIGC24

Register here: redcap.partners.org/redcap/surveys…

Dana-Farber #LynchSyndrome Center is organizing the 2nd Annual Lynch Syndrome Scientific Symposium. Hosted by Matt Yurgelun, MD & Sapna Syngal, MD it includes many expert speakers. Proud to see so many #CGAIGC members involved inc Zsofia Stadler Timothy Yen MD Ajay Bansal & more

📢Interested in submitting an abstract for the Dana-Farber #LynchSyndrome Scientific Symposium❓ ➡️The abstract submission deadline has been EXTENDED‼️ ⏱️NOW February 12, 2025, at 11:59 EST 📍Submit your abstract here👉tinyurl.com/429ystbk ✅Register here 👉

Huge thanks to TODAY and Craig Melvin for helping to spread the word on #LynchSyndrome and all of the important efforts to increase awareness, improve treatments, and maximize cancer prevention! today.com/video/inside-t…

The TODAY stopped by Dana-Farber to learn more about Lynch syndrome with Matt Yurgelun, MD and our Lynch Syndrome Center. Learn how genetic testing can help a patient with cancer's family members catch potential disease before it spreads. today.com/video/inside-t…

Marking Colorectal Cancer Awareness Month, I reported on the groundbreaking research from the Dana-Farber Cancer Institute that’s working to find cancer before it spreads. today.com/video/inside-t…

💫One of my favorite parts of Dana-Farber is the rich collaboration and focus on patient education 🗓️ March 22 is #LynchSyndrome Awareness Day #LynchSyndrome is an autosomal dominant cancer predisposition condition that increases risk of GI, GU, endometrial, and ovarian

There’s still time to join us for our Dana-Farber #LynchSyndrome Scientific Symposium all day Wed April 16. Available virtually or in-person for FREE! Register at: redcap.link/LynchSymposium…

📢#LynchSyndromeAwarenessDay may be over but the education continues ➡️Join our colleagues & friends from Dana-Farber & the wider #HereditaryGICancer community for this FREE #LynchSyndrome Scientific Symposium 🗓️Wed April 16 ⌚️9am-5pm ✍️redcap.link/LynchSymposium… 📍An impressive

Have you seen non-response to immunotherapy in locally advanced dMMR/MSI-H rectal cancer? We describe such a case with underlying MMR heterogeneity as a potential mechanism of resistance to dostarlimab. ascopubs.org/doi/abs/10.120… JCO Precision Oncology Matt Yurgelun, MD